Insider sale
FAETH THERAPEUTICS, INC.
$4.14M
155.14K shares
What this filing means
CAMBRIAN BIOPHARMA INC plans to sell 155.14K shares of FAETH THERAPEUTICS, INC. valued at approximately $4.14M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/11/2026ACC: 0001959173-26-005879
10% Owner
Since Feb 2021
155.14K
Shares to sell
$4.14M
Approx. market value
130.14K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Private Placement
Cash/Check
1/10/2020
130.14KTotal acquired130.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/10/2020 | Private Placement Cash/Check | 130.14K | — |
| Total | 130.14K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
25K
Market value
$500.5K
6/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
130.14K
Market value
$3.64M
7/22/2026
Total
Units
155.14K
Value
$4.14M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 25K | $500.5K | — | Completed |
| Planned — Approximate Date | ||||
7/22/2026 | 130.14K | $3.64M | NASDAQ | Planned |
| Total | 155.14K | $4.14M | ||